the invention relates to the pharmaceutical industry and can be used in hospitals for the treatment of tuberculosis.\u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0442\u0443\u0431\u0435\u0440\u043a\u0443\u043b\u0435\u0437\u043d\u044b\u0439 drug contains isoniazid, complex inclusion \u0446\u0438\u043a\u043b\u043e\u0434\u0435\u043a\u0441\u0442\u0440\u0438\u043d\u0430 with \u0438\u0437\u043e\u043d\u0438\u0430\u0437\u0438\u0434\u043e\u043c in \u043c\u043e\u043b\u044c\u043d\u043e\u043c ratio 1: 1, \u043a\u0440\u043e\u0441\u043f\u043e\u0432\u0438\u0434\u043e\u043d stamps \u2033\u043f\u043e\u043b\u0438\u043f\u043b\u0430\u0441\u0434\u043e\u043d xl 10 \u2033 or \u043a\u0440\u043e\u0441\u043a\u0430\u0440\u043c\u0435\u043b\u043e\u0437\u0443 sodiummannitol or aspartame, intolerant of \u2033\u0441\u0443\u043f\u0435\u0440\u0442\u0430\u0431 14SD\u2033, \u0431\u0438\u0444\u0435\u043d\u0434\u0430\u0442, a mixture of calcium \u0441\u0442\u0435\u0430\u0440\u0430\u0442\u0430 and \u0430\u044d\u0440\u043e\u0441\u0438\u043b\u0430 by weight ratio of 1: 1, with the following ratio of components the pill, mg: isoniazid 85.0 - 950 the inclusion of \u0446\u0438\u043a\u043b\u043e\u0434\u0435\u043a\u0441\u0442\u0440\u0438\u043d\u0430 with \u0438\u0437\u043e\u043d\u0438\u0430\u0437\u0438\u0434\u043e\u043c 40.0 - 120,0 \u043a\u0440\u043e\u0441\u043f\u043e\u0432\u0438\u0434\u043e\u043d stamps \u2033\u043f\u043e\u043b\u0438\u043f\u043b\u0430\u0441\u0434\u043e\u043d xl 10\u2033 or \u043a\u0440\u043e\u0441\u043a\u0430\u0440\u043c\u0435\u043b\u043e\u0437\u0430 sodium 45,0 - portugal mannitol or aspartame 30 - 600 lactose stamps \u2033\u0441\u0443\u043f\u0435\u0440\u0442\u0430\u0431 14SD\u2033 25.0 - 45,0 \u0431\u0438\u0444\u0435\u043d\u0434\u0430\u0442 3.0 - 5.0 the mixture of calcium \u0441\u0442\u0435\u0430\u0440\u0430\u0442\u0430 and \u0430\u044d\u0440\u043e\u0441\u0438\u043b\u0430 by weight ratio of 1: 1 5.0 7.6.method for the continuous mixing of \u0438\u0437\u043e\u043d\u0438\u0430\u0437\u0438\u0434
